Related Experiment Videos
Hypertensive mechanisms and converting enzyme inhibitors
C M Ferrario1, N Jaiswal, K Yamamoto
1Department of Brain and Vascular Research, Cleveland Clinic Foundation, Ohio 44195.
Clinical Cardiology
|August 1, 1991
Summary
Angiotensin-converting enzyme (ACE) inhibitors treat high blood pressure by affecting vascular tone and cardiac function. These drugs influence central nervous system mechanisms and prostaglandin synthesis for blood pressure regulation.
Area of Science:
- Cardiovascular Pharmacology
- Renal Physiology
Background:
- Angiotensin-converting enzyme (ACE) inhibitors represent a significant advancement in hypertension treatment.
- Their precise mechanisms of action in regulating blood pressure require further elucidation.
Purpose of the Study:
- To investigate the multifaceted mechanisms by which ACE inhibitors exert their antihypertensive effects.
- To explore the role of ACE inhibitors in both central and peripheral blood pressure regulation.
Main Methods:
- Review of recent experimental data and clinical findings.
- Analysis of the impact of ACE inhibitors on pressor and depressor mechanisms.
- Investigation of central nervous system actions and prostaglandin pathways.
Main Results:
- ACE inhibitors reduce angiotensin II-mediated vasoconstriction and catecholamine release.
- They restore baroreceptor activity and normalize sympathetic vasomotor activity.
- Evidence suggests central nervous system effects and enhanced vasodilator prostaglandin biosynthesis.
Conclusions:
- ACE inhibitors modulate vascular tone and cardiac function through complex mechanisms.
- Central nervous system actions and stimulation of prostaglandin synthesis contribute to their antihypertensive effects.
- These findings clarify the role of tissue renin-angiotensin systems in blood pressure control.